At follow-up , a significantly lower rate of ultrasound-detectable ovarian adhesions with the uterus and the bowel was observed in the treatment group , respectively ( 46.7 % vs 77.3 % , p = .003 and 26.7 % vs 68.2 % , p < .0005 ) .